Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.20.4
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 287 $ (1,680) $ 175,820 $ (158,981) $ 32,938
Balance, shares at Dec. 31, 2018 2,877,000 7,000      
Common stock issued $ 1 1
Common stock issued, shares 9,000        
Common stock issued through offerings, net of expenses $ 94 5,868 5,962
Common stock issued through offerings, net of expenses, shares 933,000        
Treasury stock purchased $ (32) (32)
Treasury stock purchased, shares   3,000      
Stock-based compensation expense 266 266
Adoption of ASC 842 55 55
Net loss (3,326) (3,326)
Balance at Mar. 31, 2019 $ 382 $ (1,712) 181,954 (162,252) 35,771
Balance, shares at Mar. 31, 2019 3,819,000 10,000      
Balance at Dec. 31, 2018 $ 287 $ (1,680) 175,820 (158,981) 32,938
Balance, shares at Dec. 31, 2018 2,877,000 7,000      
Net loss         (16,077)
Balance at Sep. 30, 2019 $ 383 $ (1,712) 182,361 (175,002) 6,030
Balance, shares at Sep. 30, 2019 3,829,000 10,000      
Balance at Mar. 31, 2019 $ 382 $ (1,712) 181,954 (162,252) 35,771
Balance, shares at Mar. 31, 2019 3,819,000 10,000      
Common stock issued $ 1 72 73
Common stock issued, shares 10,000        
Stock-based compensation expense 205 205
Net loss (5,304) (5,304)
Balance at Jun. 30, 2019 $ 383 $ (1,712) 182,231 (167,556) 30,829
Balance, shares at Jun. 30, 2019 3,829,000 10,000      
Dividends accrued (75) (75)
Stock-based compensation expense 205 205
Net loss (7,446) (7,446)
Balance at Sep. 30, 2019 $ 383 $ (1,712) 182,361 (175,002) 6,030
Balance, shares at Sep. 30, 2019 3,829,000 10,000      
Balance at Dec. 31, 2019 $ 393 $ (1,721) 182,514 (185,665) (4,479)
Balance, shares at Dec. 31, 2019 3,932,000 12,000      
Common stock issued $ 1 1
Common stock issued, shares 37,000        
Restricted stock issued        
Restricted stock issued, shares 6,000        
Common stock issued through market sales $ 8 476 484
Common stock issued through market sales, shares 80,000        
Common stock issued through offerings, net of expenses        
Extinguishment of Series A Shares (828) (828)
Beneficial Conversion Feature in connection with Series B Issuance 2,205 2,205
Amortization of Beneficial Conversion Feature (2,205) (2,205)
Stock-based compensation expense 418 418
Net loss (6,494) (6,494)
Balance at Mar. 31, 2020 $ 402 $ (1,721) 182,580 (192,159) 6,838
Balance, shares at Mar. 31, 2020 4,055,000 12,000      
Balance at Dec. 31, 2019 $ 393 $ (1,721) 182,514 (185,665) (4,479)
Balance, shares at Dec. 31, 2019 3,932,000 12,000      
Net loss         (18,308)
Balance at Sep. 30, 2020 $ 402 $ (1,770) 183,543 (203,973) (21,798)
Balance, shares at Sep. 30, 2020 4,060,000 19,000      
Balance at Mar. 31, 2020 $ 402 $ (1,721) 182,580 (192,159) 6,838
Balance, shares at Mar. 31, 2020 4,055,000 12,000      
Treasury stock purchased $ (49) (49)
Treasury stock purchased, shares   7,000      
Stock-based compensation expense 400 400
Net loss (5,580) (5,580)
Balance at Jun. 30, 2020 $ 402 $ (1,770) 182,980 (197,739) 1,693
Balance, shares at Jun. 30, 2020 4,055,000 19,000      
Common stock issued
Common stock issued, shares 5,000        
Stock-based compensation expense 563 563
Net loss (6,234) (6,234)
Balance at Sep. 30, 2020 $ 402 $ (1,770) $ 183,543 $ (203,973) $ (21,798)
Balance, shares at Sep. 30, 2020 4,060,000 19,000